MA26537A1 - Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant. - Google Patents

Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.

Info

Publication number: MA26537A1
Authority: MA; Morocco
Prior art keywords: novel; pharmaceutical compositions; compositions containing; aminopyridine derivatives; aminopyridine
Prior art date: 1997-08-27

Application number

MA25229A

Other languages

English (en)

Inventor

Adams Lowe John Iii

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-27

Filing date

1998-08-26

Publication date

2004-12-20

1998-08-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-20 Publication of MA26537A1 publication Critical patent/MA26537A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems

MA25229A 1997-08-27 1998-08-26 Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant. MA26537A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5709497P	1997-08-27	1997-08-27

Publications (1)

Publication Number	Publication Date
MA26537A1 true MA26537A1 (fr)	2004-12-20

Family

ID=22008463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25229A MA26537A1 (fr)	1997-08-27	1998-08-26	Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.

Country Status (40)

Country	Link
EP (1)	EP1007520B1 (fr)
JP (1)	JP3411271B2 (fr)
KR (1)	KR100367277B1 (fr)
CN (1)	CN1268133A (fr)
AP (1)	AP1213A (fr)
AR (1)	AR014110A1 (fr)
AT (1)	ATE248161T1 (fr)
AU (1)	AU8458898A (fr)
BG (1)	BG104138A (fr)
BR (1)	BR9811555A (fr)
CA (1)	CA2296313C (fr)
CO (1)	CO4970728A1 (fr)
DE (1)	DE69817584T2 (fr)
DK (1)	DK1007520T3 (fr)
DZ (1)	DZ2594A1 (fr)
EA (1)	EA003839B1 (fr)
ES (1)	ES2203976T3 (fr)
GT (1)	GT199800128A (fr)
HN (1)	HN1998000118A (fr)
HR (1)	HRP980470A2 (fr)
HU (1)	HUP0003700A3 (fr)
ID (1)	ID24087A (fr)
IL (1)	IL133958A0 (fr)
IS (1)	IS5344A (fr)
MA (1)	MA26537A1 (fr)
NO (1)	NO20000958L (fr)
NZ (1)	NZ502281A (fr)
OA (1)	OA11288A (fr)
PA (1)	PA8456901A1 (fr)
PE (1)	PE106599A1 (fr)
PL (1)	PL338987A1 (fr)
PT (1)	PT1007520E (fr)
SK (1)	SK1402000A3 (fr)
TN (1)	TNSN98154A1 (fr)
TR (1)	TR200000535T2 (fr)
UA (1)	UA55461C2 (fr)
UY (1)	UY25158A1 (fr)
WO (1)	WO1999010339A1 (fr)
YU (1)	YU10900A (fr)
ZA (1)	ZA987726B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010049379A1 (en)	1997-08-27	2001-12-06	Lowe John Adams	2-aminopyridines containing fused ring substituents
ATE272630T1 (de)	1998-04-10	2004-08-15	Japan Tobacco Inc	Amidin-verbindungen
HUP0102236A3 (en) *	1998-06-03	2003-01-28	Pfizer Prod Inc	2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors and pharmaceutical compositions containing them and their use
OA11595A (en) *	1998-08-11	2004-08-19	Pfizer Prod Inc	New pharmaceutical uses for NOS inhibitors.
ID29892A (id)	1999-02-25	2001-10-18	Pfizer Prod Inc	2-aminopiridin yang mengandung substituen-substituen cincin terlebur
GB0004151D0 (en) *	2000-02-23	2000-04-12	Astrazeneca Uk Ltd	Novel use
GB0004149D0 (en) *	2000-02-23	2000-04-12	Astrazeneca Uk Ltd	Novel compounds
GB0004153D0 (en)	2000-02-23	2000-04-12	Astrazeneca Uk Ltd	Novel use
GB0004152D0 (en)	2000-02-23	2000-04-12	Astrazeneca Uk Ltd	Novel compounds
FR2805818B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
BR0112939A (pt)	2000-08-16	2005-11-01	Upjohn Co	Compostos para o tratamento de distúrbios de dependência
CN100356917C (zh)	2001-05-15	2007-12-26	霍夫曼-拉罗奇有限公司	用作糖尿病治疗中的PPAR－α和PPAR－γ激活剂的羧酸取代的噁唑衍生物
SE0102640D0 (sv)	2001-07-31	2001-07-31	Astrazeneca Ab	Novel compounds
US20030045449A1 (en) *	2001-08-15	2003-03-06	Pfizer, Inc.	Pharmaceutical combinations for the treatment of neurodegenerative diseases
DE10159922A1 (de) *	2001-12-06	2003-06-26	Gruenenthal Gmbh	Substituierte 2-Pyrrolidin-2-yl-1H-indol-Derivate
PL374818A1 (en)	2002-07-03	2005-10-31	F.Hoffmann-La Roche Ag	Oxazole derivatives and their use as insulin sensitizers
NZ538058A (en) *	2002-08-14	2006-11-30	Neurosearch As	Quinuclidine derivatives and their use for treating disorders related to CNS and PNS
JP4533141B2 (ja)	2002-08-30	2010-09-01	エフ．ホフマン−ラロシュアーゲー	ＰＰＡＲα及びＰＰＡＲγアゴニストとしての新規２−アリールチアゾール化合物
EP1539746B1 (fr)	2002-09-12	2006-11-15	F. Hoffmann-La Roche Ag	Composes d'acide 1h-indol-5-propionique en tant qu'agonistes de ppar utiles dans le traitement du diabete
US20040092741A1 (en) *	2002-11-08	2004-05-13	Pfizer Inc	Substituted pyridines via boronic acid coupling
ATE405560T1 (de)	2002-11-25	2008-09-15	Hoffmann La Roche	Indolderivaten
US7160876B2 (en)	2003-12-22	2007-01-09	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
US7655657B2 (en)	2003-12-22	2010-02-02	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
EP1773847A2 (fr) *	2004-07-09	2007-04-18	Glaxo Group Limited	Agents antibacteriens
JP2008523058A (ja) *	2004-12-10	2008-07-03	アボット・ラボラトリーズ	縮合ビシクロ複素環置換キヌクリジン誘導体
AR068032A1 (es) *	2007-08-27	2009-10-28	Kalypays Inc	Quinolonas sustituidas con heterociclicos utiles como inhibidores de oxido nitrico sintetasa
WO2009029617A1 (fr) *	2007-08-27	2009-03-05	Kalypsys, Inc.	Quinolones substituées par diarylamine utiles comme inhibiteurs de l'oxyde nitrique synthase inductible.
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
DE102008054141A1 (de)	2008-10-31	2010-05-06	Merck Patent Gmbh	Neue Materialien für organische Elektrolumineszenzvorrichtungen
DE102009033371A1 (de)	2009-07-16	2011-05-12	Merck Patent Gmbh	Materialien für elektronische Vorrichtungen
WO2014138460A1 (fr)	2013-03-07	2014-09-12	Northwestern University	Inhibiteurs de l'oxyde nitrique synthase neuronaux sélectifs à base de 2-aminopyridine
CN104725249B (zh) *	2013-12-20	2019-02-12	广东东阳光药业有限公司	苄胺类衍生物及其在药物上的应用
WO2016073623A2 (fr)	2014-11-04	2016-05-12	Northwestern University	Inhibiteurs d'oxyde nitrique synthase d'origine bactérienne et mammalienne
US10759791B2 (en)	2014-11-04	2020-09-01	Northwestern University	Mammalian and bacterial nitric oxide synthase inhibitors
CN106478376A (zh) *	2016-10-08	2017-03-08	贵州大学	一种4‑氟萘‑1‑醇的制备工艺
CN114560779A (zh) *	2022-01-25	2022-05-31	杭州华东医药集团浙江华义制药有限公司	一种米拉贝隆关键中间体的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT400845B (de) *	1993-12-06	1996-03-25	Chem Pharm Forsch Gmbh	Neue thienothiazinderivate, ein verfahren zu ihrer herstellung und ihre verwendung
AU4515696A (en) *	1994-12-12	1996-07-03	Merck & Co., Inc.	Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
JPH08311028A (ja) *	1995-05-17	1996-11-26	Japan Tobacco Inc	２−アミノピリジン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
JPH09132529A (ja) *	1995-11-09	1997-05-20	Ono Pharmaceut Co Ltd	一酸化窒素合成酵素阻害剤
CN1168719C (zh) *	1996-03-29	2004-09-29	辉瑞大药厂	6-苯基吡啶-2-基胺衍生物以及药物组合物和用途
HN1997000027A (es) *	1996-12-06	1997-06-05	Pfizer Prod Inc	Derivados de 6-fenil piridil - 2 amina

1998
- 1998-07-29 HN HN1998000118A patent/HN1998000118A/es unknown
- 1998-08-10 PA PA19988456901A patent/PA8456901A1/es unknown
- 1998-08-10 GT GT199800128A patent/GT199800128A/es unknown
- 1998-08-11 HU HU0003700A patent/HUP0003700A3/hu unknown
- 1998-08-11 WO PCT/IB1998/001229 patent/WO1999010339A1/fr not_active Application Discontinuation
- 1998-08-11 BR BR9811555-3A patent/BR9811555A/pt not_active Application Discontinuation
- 1998-08-11 ES ES98935249T patent/ES2203976T3/es not_active Expired - Lifetime
- 1998-08-11 SK SK140-2000A patent/SK1402000A3/sk unknown
- 1998-08-11 AU AU84588/98A patent/AU8458898A/en not_active Abandoned
- 1998-08-11 AT AT98935249T patent/ATE248161T1/de not_active IP Right Cessation
- 1998-08-11 DK DK98935249T patent/DK1007520T3/da active
- 1998-08-11 NZ NZ502281A patent/NZ502281A/xx unknown
- 1998-08-11 ID IDW20000198A patent/ID24087A/id unknown
- 1998-08-11 CN CN98808577A patent/CN1268133A/zh active Pending
- 1998-08-11 DE DE69817584T patent/DE69817584T2/de not_active Expired - Fee Related
- 1998-08-11 EA EA200000171A patent/EA003839B1/ru not_active IP Right Cessation
- 1998-08-11 CA CA002296313A patent/CA2296313C/fr not_active Expired - Fee Related
- 1998-08-11 KR KR10-2000-7001017A patent/KR100367277B1/ko not_active IP Right Cessation
- 1998-08-11 TR TR2000/00535T patent/TR200000535T2/xx unknown
- 1998-08-11 JP JP2000507668A patent/JP3411271B2/ja not_active Expired - Fee Related
- 1998-08-11 YU YU10900A patent/YU10900A/sh unknown
- 1998-08-11 PL PL98338987A patent/PL338987A1/xx unknown
- 1998-08-11 IL IL13395898A patent/IL133958A0/xx unknown
- 1998-08-11 PT PT98935249T patent/PT1007520E/pt unknown
- 1998-08-11 EP EP98935249A patent/EP1007520B1/fr not_active Expired - Lifetime
- 1998-08-24 PE PE1998000772A patent/PE106599A1/es not_active Application Discontinuation
- 1998-08-25 AR ARP980104224A patent/AR014110A1/es not_active Application Discontinuation
- 1998-08-26 ZA ZA9807726A patent/ZA987726B/xx unknown
- 1998-08-26 TN TNTNSN98154A patent/TNSN98154A1/fr unknown
- 1998-08-26 DZ DZ980204A patent/DZ2594A1/fr active
- 1998-08-26 MA MA25229A patent/MA26537A1/fr unknown
- 1998-08-26 UY UY25158A patent/UY25158A1/es unknown
- 1998-08-27 AP APAP/P/1998/001330A patent/AP1213A/en active
- 1998-08-27 HR HR60/057,094A patent/HRP980470A2/hr not_active Application Discontinuation
- 1998-08-27 CO CO98049140A patent/CO4970728A1/es unknown
- 1998-11-08 UA UA2000010298A patent/UA55461C2/uk unknown
2000
- 2000-01-14 IS IS5344A patent/IS5344A/is unknown
- 2000-02-08 BG BG104138A patent/BG104138A/xx unknown
- 2000-02-18 OA OA1200000037A patent/OA11288A/en unknown
- 2000-02-25 NO NO20000958A patent/NO20000958L/no unknown

Also Published As

Publication number	Publication date
AP9801330A0 (en)	1998-09-30
ID24087A (id)	2000-07-06
HN1998000118A (es)	1999-02-09
BG104138A (en)	2000-11-30
NO20000958L (no)	2000-04-14
PL338987A1 (en)	2000-12-04
AP1213A (en)	2003-10-07
KR20010022433A (ko)	2001-03-15
HRP980470A2 (en)	1999-06-30
CA2296313C (fr)	2004-11-02
DZ2594A1 (fr)	2003-02-22
CN1268133A (zh)	2000-09-27
PE106599A1 (es)	1999-11-02
UA55461C2 (uk)	2003-04-15
SK1402000A3 (en)	2000-07-11
BR9811555A (pt)	2000-09-12
AU8458898A (en)	1999-03-16
EP1007520B1 (fr)	2003-08-27
NO20000958D0 (no)	2000-02-25
IS5344A (is)	2000-01-14
TNSN98154A1 (fr)	2005-03-15
IL133958A0 (en)	2001-04-30
EA200000171A1 (ru)	2000-10-30
EP1007520A1 (fr)	2000-06-14
PT1007520E (pt)	2003-12-31
WO1999010339A1 (fr)	1999-03-04
ES2203976T3 (es)	2004-04-16
JP2001514176A (ja)	2001-09-11
JP3411271B2 (ja)	2003-05-26
YU10900A (sh)	2002-12-10
ATE248161T1 (de)	2003-09-15
DE69817584D1 (de)	2003-10-02
ZA987726B (en)	2000-02-28
CO4970728A1 (es)	2000-11-07
KR100367277B1 (ko)	2003-01-09
CA2296313A1 (fr)	1999-03-04
OA11288A (en)	2003-08-22
DK1007520T3 (da)	2003-11-24
PA8456901A1 (es)	2000-05-24
AR014110A1 (es)	2001-02-07
HUP0003700A2 (hu)	2001-10-28
HUP0003700A3 (en)	2002-09-30
DE69817584T2 (de)	2004-04-01
TR200000535T2 (tr)	2000-11-21
UY25158A1 (es)	2000-12-29
GT199800128A (es)	2000-02-01
NZ502281A (en)	2002-09-27
EA003839B1 (ru)	2003-10-30

Publication	Publication Date	Title
MA26537A1 (fr)	2004-12-20	Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
DZ2086A1 (fr)	2002-07-22	Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
MA26453A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2 amine et compositions pharmaceutiques les contenant
DZ2461A1 (fr)	2003-01-18	Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2805818B1 (fr)	2002-04-26	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
DZ1916A1 (fr)	2002-02-17	Composés nouveaux et compostions pharmaceutiques les contenant.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26553A1 (fr)	2004-12-20	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2772030B1 (fr)	2000-01-28	Nouveaux derives silicies de benz-x-azoles filtres, compositions cosmetiques photoprotectrices les contenant et utilisations
FR2807038B1 (fr)	2002-08-16	Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
FR2742751B1 (fr)	1998-01-30	Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
MA26422A1 (fr)	2004-12-20	Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.
FR2811992B1 (fr)	2003-07-04	Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
MA26519A1 (fr)	2004-12-20	Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2779724B1 (fr)	2001-04-20	Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2731706B1 (fr)	1997-04-11	Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
MA26552A1 (fr)	2004-12-20	Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2732968B1 (fr)	1997-05-16	Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2796380B3 (fr)	2001-08-17	Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2757166B1 (fr)	1999-01-29	Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2687151B1 (fr)	1994-03-25	Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2732342B1 (fr)	1997-04-30	Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent